Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN15591075
ISRCTN15591075
Completed
未知

A preliminary safety and efficacy evaluation of direct intrapancreatic tail delivery of autologous bone marrow-derived cells in Egyptian patients with type 1 diabetes mellitus

Wadi EL-Neel hospital (JCI)0 sites3 target enrollmentMay 2, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsType 1 diabetes mellitusDigestive System

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 1 diabetes mellitus
Sponsor
Wadi EL-Neel hospital (JCI)
Enrollment
3
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 2, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Wadi EL-Neel hospital (JCI)

Eligibility Criteria

Inclusion Criteria

  • •1\. Males and females aged between 2 to 30 years of age
  • •2\. Confirmed T1D based on the American Diabetes association (ADA) 2015 criteria for diagnosis
  • •3\. Body mass index (BMI) of \= 29\.9

Exclusion Criteria

  • •1\. Active infections
  • •2\. Any chronic or acute illness
  • •3\. Antibodies to hepatitis B surface antigen
  • •4\. Hepatitis C
  • •5\. Human immunodeficiency virus or evidence of diabetic complications at baseline
  • •6\. Pregnant, are breast\-feeding or intend to become pregnant during the study
  • •7\. Clinically relevant uncontrolled medical conditions not associated with diabetes (such as hematologic, renal, hepatic, neurologic, cardiac and respiratory conditions)
  • •8\. Evidence of active malignancy or a prior history of active malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 2
PMX-DHP for COVID-19
JPRN-jRCTs032200131Izumi Shinnyuu30
Completed
Not Applicable
To determine the safety and effectiveness of Dandruff ControlOil Shots in dandruff reduction in Healthy Adult HumanSubjects with Dandruff on the scalp
CTRI/2022/04/041701Brillare Science Private Limited16
Active, not recruiting
Not Applicable
A study of DoTiNurad aiming to treat hyperuricemia with CKDPatients with hyperuricemia whose renal function is in the GFR range of G1 to G4
JPRN-jRCTs061210079Wada Jun100
Completed
Not Applicable
To evaluate the efficacy and safety of the newly developed low-intensity ultrasound-transcutaneous nerve stimulation combined therapy for knee pain with osteoarthritis for 20 minutes, 3 times a day (more than 10 times a week) for a total of 8 weeks Single-institution, double-blind, randomized, parallel design, study-based clinical trials
KCT0003883Chonbuk National University Hospital40
Completed
Phase 4
Comparison of efficacy and safety of Drotaverine Versus Mebeverine in Irritable Bowel Syndrome
CTRI/2017/11/010529Walter Bushnell Pvt Ltd200